TOM Kits logo

Emergent Drug Panel Kit (EDP Kit)

Print
Related Pages

The EDP Kit contains reference materials that support laboratory screening for 60 emergent synthetic opioids, benzodiazepines, stimulants, hallucinogens, and synthetic cannabinoids.

These materials are distributed by Cayman Chemical, an ISO-accredited reference material producer, to labs in the US and its territories. Labs eligible to apply for the EDP kit must have a valid DEA controlled substance registration for Schedule I controlled substances.

Traceable Opioid Material® Kits are reference materials and do not eliminate the need to meet analytical method requirements of other federal agencies or the need to comply with state and local regulations. Traceable Opioid Material® Kits are not for diagnostic use.

Fentanyl Analog Screening Kit (FAS Kit) and Emergent Panels contents and packaging
Other TOM Kits® Products and Resources

Fentanyl Analog Screening Kit and Emergent Panels (FAS, FAS V1-V4 Kits)

High-Resolution Mass Spectral Libraries for Opioid Analysis

Compounds in the EDP Kit

Additional Product Information

  • Includes 200 micrograms of each compound
  • Includes the most prevalent compounds identified on DEA Emerging Threat Reports and CFSRE Scope and Trend Reports (2019-2022)
  • Improves immunoassay and mass spectrometry screening methods

Safety Data Sheets, Certificates of Analyses, and Other Product-Specific Documents

Request the EDP Kit

Publications

Designing Traceable Opioid Material* Kits to Improve Laboratory Testing during the U.S. Opioid Overdose Crisis

Application of the Fentanyl Analog Screening Kit toward the Identification of Emerging Synthetic Opioids in Human Plasma and Urine by LC-QTOF

TOM Kits logo, TRACEABLE OPIOID MATERIAL®, and TOM Kits® are registered marks of HHS.